Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Krogsgaard

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Human Pathology|July 31, 2016
Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanomaSarah A Weiss, Sung Won Han, Kevin Lui, et al.
Human Pathology|April 29, 2017
Corrigendum to "Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma" (Hum Pathol 2016;57:116-25)Sarah A Weiss, Sung Won Han, Kevin Lui, et al.
Research Square|February 13, 2023
Structural Basis for Self-Discrimination by Neoantigen-Specific TCRsJohn P Finnigan, Jenna H Newman, Yury Patskovsky, et al.
Journal for Immunotherapy of Cancer|April 19, 2020
C reactive protein impairs adaptive immunity in immune cells of patients with melanomaTatsuya Yoshida, Junya Ichikawa, Iulia Giuroiu, et al.
Nature Communications|March 8, 2024
Structural basis for self-discrimination by neoantigen-specific TCRsJohn P Finnigan, Jenna H Newman, Yury Patskovsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchangeMelissa J Call, Xuechao Xing, Gregory D Cuny, et al.
Msystems|February 27, 2025
Association of tumor microbiome with survival in resected early-stage PDACYixuan Meng, Chan Wang, Mykhaylo Usyk, et al.
Journal of Cellular Immunology|March 9, 2026
Mechanisms and Therapeutic Strategies to Overcome Immune Checkpoint Inhibitor Resistance in Melanoma, Head and Neck, and Triple-Negative Breast CancersIryna Voloshyna, Apoorvi Tyagi, Stanzin Idga, et al.
Nature Communications|May 5, 2023
Catch bond models may explain how force amplifies TCR signaling and antigen discriminationHyun-Kyu Choi, Peiwen Cong, Chenghao Ge, et al.
EMBO Reports|November 7, 2024
In situ cell-surface conformation of the TCR-CD3 signaling complexAswin Natarajan, Yogambigai Velmurugu, Manuel Becerra Flores, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Human Pathology|July 31, 2016
Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanomaSarah A Weiss, Sung Won Han, Kevin Lui, et al.
Human Pathology|April 29, 2017
Corrigendum to "Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma" (Hum Pathol 2016;57:116-25)Sarah A Weiss, Sung Won Han, Kevin Lui, et al.
Research Square|February 13, 2023
Structural Basis for Self-Discrimination by Neoantigen-Specific TCRsJohn P Finnigan, Jenna H Newman, Yury Patskovsky, et al.
Journal for Immunotherapy of Cancer|April 19, 2020
C reactive protein impairs adaptive immunity in immune cells of patients with melanomaTatsuya Yoshida, Junya Ichikawa, Iulia Giuroiu, et al.
Nature Communications|March 8, 2024
Structural basis for self-discrimination by neoantigen-specific TCRsJohn P Finnigan, Jenna H Newman, Yury Patskovsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchangeMelissa J Call, Xuechao Xing, Gregory D Cuny, et al.
Msystems|February 27, 2025
Association of tumor microbiome with survival in resected early-stage PDACYixuan Meng, Chan Wang, Mykhaylo Usyk, et al.
Journal of Cellular Immunology|March 9, 2026
Mechanisms and Therapeutic Strategies to Overcome Immune Checkpoint Inhibitor Resistance in Melanoma, Head and Neck, and Triple-Negative Breast CancersIryna Voloshyna, Apoorvi Tyagi, Stanzin Idga, et al.
Nature Communications|May 5, 2023
Catch bond models may explain how force amplifies TCR signaling and antigen discriminationHyun-Kyu Choi, Peiwen Cong, Chenghao Ge, et al.
EMBO Reports|November 7, 2024
In situ cell-surface conformation of the TCR-CD3 signaling complexAswin Natarajan, Yogambigai Velmurugu, Manuel Becerra Flores, et al.
Pageof 7